West Announces Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Wells Fargo Upgrades West Pharmaceutical (WST) to Outperform
October 28, 2016 7:11 AM EDTWells Fargo upgraded West Pharmaceutical (NYSE: WST) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.
Shares of West Pharmaceutical closed at $72.42 yesterday.
... MoreWest Pharma (WST) Reports In-Line Q3 EPS; Narrows EPS Outlook
October 27, 2016 8:16 AM EDTWest Pharma (NYSE: WST) reported Q3 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $376.7 million versus the consensus estimate of $371.25 million.
GUIDANCE:
West Pharma sees FY2016 EPS of $2.17-$2.22, versus prior guidance of... More
